Atlas of Non-FDG PET–CT in Diagnostic Oncology

Please use this identifier to cite or link to this item: http://elibrary.nnra.gov.ng/jspui/handle/123456789/878

Full metadata record

DC Field	Value	Language
dc.contributor.author	IAEA	-
dc.date.accessioned	2022-05-23T14:35:35Z	-
dc.date.available	2022-05-23T14:35:35Z	-
dc.date.issued	2022	-
dc.identifier.issn	ISSN 2075–3772	-
dc.identifier.uri	http://elibrary.nnra.gov.ng/jspui/handle/123456789/878	-
dc.description	This publication provide a case based presentation of the normal biodistribution, variants and pitfalls, and different imaging patterns for the main indications for each of the new non 18F-FDG PET radiopharmaceuticals. This should facilitate the interpretation of non-18F-FDG PET–CT procedures in order to ensure that, in clinical practice, the study report is accurate and helpful. in other words, the main objective of the human health series is to enhance the capabilities of IAEA Member States so as to prevent, diagnosis and treatment of health problems through the development and application of Nuclear techniques, within a framework of quality assurance.	en_US
dc.language.iso	en	en_US
dc.publisher	NNRA e-library	en_US
dc.relation.ispartofseries	IAEAL 21-01410;	-
dc.subject	Tomography and Emission	en_US
dc.subject	Cancer Radionuclide imaging	en_US
dc.title	Atlas of Non-FDG PET–CT in Diagnostic Oncology	en_US
dc.type	Book	en_US
Appears in Collections:	Human Health

Files in This Item:

File	Description	Size	Format
Atlas of Non-FDG PET–CT.pdf		23.69 MB	Adobe PDF	View/Open

NNRA e-Library